Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Solutions of lactic acid salts of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids|
|Abstract:||The invention relates to solutions of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids, and in particular both ready-to-use injection and/or infusion solutions and dosage forms which can be converted into such injection and/or infusion solutions before use. The solutions according to the invention are characterized in that, besides the lactic acid salts of the active substance and, if appropriate, customary auxiliaries, they additonally contain at least one acid which does not lead to precipitates, in particular lactic acid.|
|Inventor(s):||Grohe; Klaus (Odenthal, DE), Lammens; Robert (Leverkusen, DE)|
|Assignee:||Bayer Aktiengesellschaft (Leverkusen, DE)|
|Filing Date:||May 12, 1986|
|Claims:||1. An aqueous storage stable solution which can be converted into an injection or diffusion solution consisting essentially of (a) a lactic acid salt of a piperazinylquinolonecarboxylic acid of the formula ##STR2## in which R.sub.1 denotes hydrogen, methyl, ethyl or .beta.-hydroxyethyl, |
R.sub.3 denotes hydrogen, methyl or ethyl,
and (b) and excess acid selected from the group consisting of methanesulphonic acid, propionic acid, succinic acid, hydrochloric acid and lactic acid in an amount which does not lead to precipitates and constituting about 0.01 to 90% based on the solution.
2. A solution according to claim 1, wherein the excess acid is present in about 0.01 to 25%.
3. A solution according to claim 1, wherein the excess acid is present in the solution in a concentration of from 0.025 to 1.4%.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.